Immatics N.V. (IMTX) vs PROCEPT BioRobotics Corporation (PRCT)

A side-by-side comparison of Immatics N.V. and PROCEPT BioRobotics Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — IMTX vs PRCT

growth of $100 · dividends reinvested · last 5y
IMTX -47.2% (-12.0%/yr)PRCT -57.5% (-15.7%/yr)IMTX compounded faster over this window
50100150200250Start $10020222023202420252026$53$42
IMTX PRCT

IMTX vs PRCT: by the numbers

  • •IMTX is the larger company ($1.01B vs $989M market cap).
  • •Both run net losses; PRCT's is the smaller (-32.54% vs -493.26% net margin).
  • •PRCT grew revenue faster over the past five years (74.27% vs 6.40% CAGR).

Metrics side by side

Valuation

MetricIMTXPRCT
P/S ratio20.762.93
P/B ratio2.212.91

Profitability

MetricIMTXPRCT
Gross margin100.00%63.74%
Operating margin-377.11%-33.86%
Net margin-493.26%-32.54%
ROE-52.47%-32.27%
ROIC-53.36%-27.51%

Growth (annualized)

MetricIMTXPRCT
Revenue CAGR (5Y)6.40%74.27%
Total return CAGR (5Y)-9.88%-14.36%

Frequently asked

Which has grown faster, IMTX or PRCT?
Over the past five years, PRCT grew revenue faster — IMTX at a 6.40% CAGR versus PRCT at 74.27%.
How have IMTX and PRCT total returns compared?
Over the past 5 years, IMTX delivered -9.88% and PRCT delivered -14.36% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.